Lemmers, R. J. L. F., van der Stoep, N., van der Vliet, P. J., Moore, S. A., Granado, D. S. L., Johnson, K., . . . van der Maarel, S. M. (2019). SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain. J Med Genet.
Styl cytowania ChicagoLemmers, Richard J L F., et al. "SMCHD1 Mutation Spectrum for Facioscapulohumeral Muscular Dystrophy Type 2 (FSHD2) and Bosma Arhinia Microphthalmia Syndrome (BAMS) Reveals Disease-specific Localisation of Variants in the ATPase Domain." J Med Genet 2019.
Styl cytowania MLALemmers, Richard J L F., et al. "SMCHD1 Mutation Spectrum for Facioscapulohumeral Muscular Dystrophy Type 2 (FSHD2) and Bosma Arhinia Microphthalmia Syndrome (BAMS) Reveals Disease-specific Localisation of Variants in the ATPase Domain." J Med Genet 2019.